According to Cancer Research UK, cancer survival in the UK has multiplied in the last 40 years. More people are surviving cancer than ever before, but living with cancer and the effects of its medicine can have complicated and long-lasting repercussions on people’s physical, emotional and social wellbeing. This is not to mention the impact on their families and networks.
To make this easy, London-based digital healthtech startup Vinehealth has built an app to offer personalised support for cancer patients to improve their quality of life. Now, the healthtech startup has bagged $5.5 million funding to expand its footprint.
US expansion plans
Talis Capital led the late-seed investment round alongside participation from existing investors – Ascension and Playfair Capital. Also, the company is in plans to raise a Series A investment in the next 12 to 18 months.
A slew of angel investors including Keith Gibbs, ex-CEO of AXA PPP Healthcare; Voyagers Health-Tech Fund, Pam Garside, partner at Newhealth, Deepali Nangia, venture partner at Atomico Angel and Speedinvest; and KHP MedTech Innovations, which is a collaboration between King’s College Hospital NHS Foundation Trust, King’s College London, and Guy’s and St Thomas’ NHS Trust participated in the round.
The latest funding comes after the £1M Biomedical Catalyst grant, the female-founded startup secured back in Feb 2021.
Vinehealth will use the funds to expand its presence in the US market. It aims to launch in the US early in 2022 and double its team of 18 in six months. For now, the patient support app is available for download for cancer patients in the UK and Ireland for free.
Founded in 2018 by Rayna Patel, an NHS physician and Georgina Kirby, a data scientist, Vinehealth aims to help patients struggling with cancer manage their symptoms and condition via its app. The founders started the company to revolutionise cancer care for patients worldwide.
Besides helping cancer patients with self-care, it also makes it easier to gather PRO (patient-reported outcome) data, including clinical trials and drug development. Its platform supports drug companies to recruit patients for their trials and help with R&D, as well as drug development.
Timely patient support
Vinehealth combines AI and behavioural science to deliver timely support for cancer patients. It also nudges them with medication reminders to easily manage their treatment by themselves. Vinehealth aims to become a channel for patients to remotely monitor their clinicians as they give feedback on symptoms and come up with side effects caused by the treatment.
Vinehealth has eliminated the traditional questionnaire that cancer patients fill in during their visits to report their symptoms and provide feedback with digitisation. It has moved the legacy process into a user-friendly and digital interface for improved quality of life of cancer patients.
The company incorporates more advanced suggestions into the app with AI, such as predictive symptom logging. The healthcare startup has built a recommender system, which is specialised in oncology and provides personalised support to the patient.
Received CE certification
Back in May this year, Vinehealth received the CE mark for its Vinehealth Cancer Companion mobile app for patients and the VinehealthPRO web app for clinicians. The CE mark will let Vinehealth enhance the features bundled with its mobile and desktop apps and deliver value to healthcare professionals, patients, and life science partners.